adenine has been researched along with Urinary Lithiasis in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of 2,8-dihydroxyadenine (DHA) urolithiasis in a 65-year-old male." | 8.02 | [A Case Report of 2,8-Dihydroxyadenine Urolithiasis]. ( Horiuchi, E; Imamura, T; Miyachi, S, 2021) |
| "We have recently encountered patients incorrectly diagnosed with adenine phosphoribosyltransferase (APRT) deficiency due to misidentification of kidney stones as 2,8-dihydroxyadenine (DHA) stones." | 7.96 | Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series. ( Edvardsson, VO; Goldfarb, DS; Ketteridge, D; Lin, TL; Michael, M; Palsson, R; Rich, PR; Runolfsdottir, HL; Sayer, JA, 2020) |
| "2,8-Dihydroxyadenine (2,8-DHA) urolithiasis in people is caused by autosomal recessive mutations in the adenine phosphoribosyltransferase gene (APRT)." | 7.80 | An APRT mutation is strongly associated with and likely causative for 2,8-dihydroxyadenine urolithiasis in dogs. ( Furrow, E; Lulich, JP; Osborne, CA; Pfeifer, RJ, 2014) |
| "Adenine phosphoribosyl transferase (APRT) deficiency is an autosomal recessive disorder and a rare cause of urolithiasis due to mutations in APRT (OMIM #102600)." | 5.41 | Adenine phosphoribosyl transferase (APRT) deficiency and a novel sequence variant in APRT with phenotypic diversity and a literature review. ( Cham, BWM; Chong, SL; Koh, AL; Leow, EH; Ng, YH; Tan, ES; Yap, CJY, 2023) |
| "Adenine phosphoribosyltransferase (APRT) deficiency is a genetic disorder that causes 2,8-dihydroxyadenine (DHA) urolithiasis." | 4.84 | [Adenine phosphoribosyltransferase deficiency and its purine metabolism]. ( Taniguchi, A, 2008) |
| "We report a case of 2,8-dihydroxyadenine (DHA) urolithiasis in a 65-year-old male." | 4.02 | [A Case Report of 2,8-Dihydroxyadenine Urolithiasis]. ( Horiuchi, E; Imamura, T; Miyachi, S, 2021) |
| "We have recently encountered patients incorrectly diagnosed with adenine phosphoribosyltransferase (APRT) deficiency due to misidentification of kidney stones as 2,8-dihydroxyadenine (DHA) stones." | 3.96 | Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series. ( Edvardsson, VO; Goldfarb, DS; Ketteridge, D; Lin, TL; Michael, M; Palsson, R; Rich, PR; Runolfsdottir, HL; Sayer, JA, 2020) |
| "Adenine phosphoribosyltransferase (APRT) deficiency is a hereditary purine metabolism disorder that causes kidney stones and chronic kidney disease (CKD)." | 3.91 | Long-term renal outcomes of APRT deficiency presenting in childhood. ( Agustsdottir, IM; Edvardsson, VO; Indridason, OS; Palsson, R; Runolfsdottir, HL, 2019) |
| "Adenine phosphoribosyltransferase (APRT) deficiency is a rare, but significant, cause of kidney stones and progressive chronic kidney disease." | 3.88 | Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial. ( Edvardsson, VO; Eiriksson, F; Goldfarb, DS; Oddsdottir, GS; Palsson, R; Runolfsdottir, HL; Sch Agustsdottir, IM; Thorsteinsdottir, M; Thorsteinsdottir, UA, 2018) |
| "2,8-Dihydroxyadenine (2,8-DHA) urolithiasis in people is caused by autosomal recessive mutations in the adenine phosphoribosyltransferase gene (APRT)." | 3.80 | An APRT mutation is strongly associated with and likely causative for 2,8-dihydroxyadenine urolithiasis in dogs. ( Furrow, E; Lulich, JP; Osborne, CA; Pfeifer, RJ, 2014) |
| "Adenine phosphoribosyltransferase deficiency is a rare autosomal recessive disorder manifesting as urolithiasis or crystalline nephropathy." | 3.80 | Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction. ( Hemmilä, U; Kaartinen, K; Kouri, T; Mäkelä, S; Räisänen-Sokolowski, A; Salmela, K, 2014) |
| " After a genetic diagnosis, febuxostat treatment was started on postoperative day 7, with the dosage gradually increased to 80 mg/day until complete the disappearance of 2,8-DHA crystals." | 1.46 | Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation. ( Kimura, T; Kurosawa, A; Nanmoku, K; Shimizu, T; Shinzato, T; Yagisawa, T, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 14 (66.67) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Miyachi, S | 1 |
| Imamura, T | 1 |
| Horiuchi, E | 1 |
| Leow, EH | 1 |
| Chong, SL | 1 |
| Tan, ES | 1 |
| Koh, AL | 1 |
| Cham, BWM | 1 |
| Yap, CJY | 1 |
| Ng, YH | 1 |
| Bagai, S | 1 |
| Khullar, D | 1 |
| Bansal, B | 1 |
| Klinkhammer, BM | 1 |
| Djudjaj, S | 1 |
| Kunter, U | 1 |
| Palsson, R | 5 |
| Edvardsson, VO | 5 |
| Wiech, T | 1 |
| Thorsteinsdottir, M | 3 |
| Hardarson, S | 1 |
| Foresto-Neto, O | 1 |
| Mulay, SR | 1 |
| Moeller, MJ | 1 |
| Jahnen-Dechent, W | 1 |
| Floege, J | 1 |
| Anders, HJ | 1 |
| Boor, P | 1 |
| Runolfsdottir, HL | 4 |
| Lin, TL | 1 |
| Goldfarb, DS | 2 |
| Sayer, JA | 1 |
| Michael, M | 1 |
| Ketteridge, D | 1 |
| Rich, PR | 1 |
| Cheng, Y | 1 |
| Guo, L | 1 |
| Wang, M | 1 |
| Chen, J | 1 |
| Wang, R | 1 |
| Nanmoku, K | 1 |
| Kurosawa, A | 1 |
| Shinzato, T | 1 |
| Shimizu, T | 1 |
| Kimura, T | 1 |
| Yagisawa, T | 1 |
| Thorsteinsdottir, UA | 2 |
| Sch Agustsdottir, IM | 1 |
| Oddsdottir, GS | 1 |
| Eiriksson, F | 1 |
| Oomatia, A | 1 |
| Dupont, P | 1 |
| Bass, P | 1 |
| Moochhala, S | 1 |
| Agustsdottir, IM | 2 |
| Indridason, OS | 1 |
| Lau, NKC | 1 |
| Ng, SKW | 1 |
| Chan, IHS | 1 |
| Ng, KS | 1 |
| Kwok, JSS | 1 |
| Furrow, E | 1 |
| Pfeifer, RJ | 1 |
| Osborne, CA | 1 |
| Lulich, JP | 1 |
| Kaartinen, K | 1 |
| Hemmilä, U | 1 |
| Salmela, K | 1 |
| Räisänen-Sokolowski, A | 1 |
| Kouri, T | 1 |
| Mäkelä, S | 1 |
| Yamaguchi, S | 1 |
| Haba, T | 1 |
| Koike, H | 1 |
| George, SA | 1 |
| Al-Rushaidan, S | 1 |
| Francis, I | 1 |
| Soonowala, D | 1 |
| Nampoory, MRN | 1 |
| Eiriksson, FF | 1 |
| Oddsdottir, S | 1 |
| Sigurdsson, BB | 1 |
| Hardarson, HK | 1 |
| Kamble, NR | 1 |
| Sigurdsson, ST | 1 |
| Fabbiani, M | 1 |
| Bracciale, L | 1 |
| Doino, M | 1 |
| D'Avino, A | 1 |
| Marzocchetti, A | 1 |
| Navarra, P | 1 |
| Cauda, R | 1 |
| De Luca, A | 1 |
| Di Giambenedetto, S | 1 |
| Nozue, H | 1 |
| Kamoda, T | 1 |
| Saitoh, H | 1 |
| Ichikawa, K | 1 |
| Taniguchi, A | 2 |
| Bollée, G | 1 |
| Harambat, J | 1 |
| Bensman, A | 1 |
| Knebelmann, B | 1 |
| Daudon, M | 1 |
| Ceballos-Picot, I | 1 |
| D'Ettorre, G | 1 |
| Zaffiri, L | 1 |
| Ceccarelli, G | 1 |
| Massetti, AP | 1 |
| Mastroianni, CM | 1 |
| Vullo, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study for the Evaluation of the Safety and the Feasibility of Treatment Simplification to Atazanavir/Ritonavir + Lamivudine in Patients Stably Treated With Two NRTIs + Atazanavir/Ritonavir With Optimal Virologic Response.[NCT00885482] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00885482)
Timeframe: 48 weeks
| Intervention | patients (Number) |
|---|---|
| Single Arm | 1 |
5 reviews available for adenine and Urinary Lithiasis
| Article | Year |
|---|---|
Adenine phosphoribosyl transferase (APRT) deficiency and a novel sequence variant in APRT with phenotypic diversity and a literature review.
Topics: Adenine; Adenine Phosphoribosyltransferase; Child; Humans; Male; Microscopy; Urinalysis; Urolithiasi | 2023 |
Recurrence of 2,8-dihydroxyadenine Crystalline Nephropathy in a Kidney Transplant Recipient: A Case Report and Literature Review.
Topics: Adenine; Adenine Phosphoribosyltransferase; Humans; Kidney Transplantation; Urolithiasis | 2021 |
[A Case Report of 2,8-Dihydroxyadenine Stone].
Topics: Adenine; Adenine Phosphoribosyltransferase; Female; Humans; Metabolism, Inborn Errors; Middle Aged; | 2015 |
Adenine phosphoribosyltransferase deficiency.
Topics: Adenine; Adenine Phosphoribosyltransferase; Allopurinol; Animals; Biomarkers; Disease Progression; E | 2012 |
[Adenine phosphoribosyltransferase deficiency and its purine metabolism].
Topics: Adenine; Adenine Phosphoribosyltransferase; Alleles; Asian People; Genotype; Humans; Mutation; Purin | 2008 |
1 trial available for adenine and Urinary Lithiasis
| Article | Year |
|---|---|
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients.
Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Drug Administration Schedule; Drug Therapy, Com | 2011 |
15 other studies available for adenine and Urinary Lithiasis
| Article | Year |
|---|---|
[A Case Report of 2,8-Dihydroxyadenine Urolithiasis].
Topics: Adenine; Adenine Phosphoribosyltransferase; Aged; Humans; Kidney Calculi; Lithotripsy; Male; Metabol | 2021 |
Rare crystalline nephropathy leading to acute graft dysfunction: a case report.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Allopurinol; Antimetabolites; Biopsy; Crystalliza | 2019 |
Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Animals; Cohort Studies; Diet; Disease Models, An | 2020 |
Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adolescent; Adult; Child; Child, Preschool; Female; Huma | 2020 |
Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Febuxostat; Gout Suppressants; Humans; Kidney Tra | 2017 |
Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Aged; Allopurinol; Cross-Over Studies; Enzyme Inh | 2018 |
The Case | Shining a light on an unusual case of chronic kidney disease.
Topics: Adenine; Adenine Phosphoribosyltransferase; Aged; Biopsy; Crystallization; Humans; Kidney; Male; Met | 2018 |
Long-term renal outcomes of APRT deficiency presenting in childhood.
Topics: Acute Kidney Injury; Adenine; Adenine Phosphoribosyltransferase; Adolescent; Adult; Allopurinol; Chi | 2019 |
Urinary bladder stone due to adenine phosphoribosyltransferase deficiency: first genetically confirmed case in a Chinese patient.
Topics: Adenine; Adenine Phosphoribosyltransferase; Asian People; Child, Preschool; Early Diagnosis; Humans; | 2019 |
An APRT mutation is strongly associated with and likely causative for 2,8-dihydroxyadenine urolithiasis in dogs.
Topics: Adenine; Adenine Phosphoribosyltransferase; Animals; Dogs; High-Throughput Nucleotide Sequencing; Ho | 2014 |
Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction.
Topics: Adenine; Adenine Phosphoribosyltransferase; Allografts; Humans; Kidney Calculi; Kidney Transplantati | 2014 |
2,8-Dihydroxyadenine Nephropathy Identified as Cause of End-Stage Renal Disease After Renal Transplant.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Allopurinol; Biomarkers; Biopsy; Enzyme Inhibitor | 2017 |
Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency.
Topics: Adenine; Adenine Phosphoribosyltransferase; Adult; Chromatography, High Pressure Liquid; Humans; Lim | 2016 |
A Japanese boy with adenine phosphoribosyltransferase (APRT) deficiency caused by compound heterozygosity including a novel missense mutation in APRT gene.
Topics: Adenine; Adenine Phosphoribosyltransferase; Asian People; Child, Preschool; Humans; Lithotripsy; Mal | 2011 |
Urolithiasis under atazanavir boosted and tenofovir therapy: a case report.
Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Atazanavir Sulfate; HIV Infections; Humans; Male; | 2008 |